ÌÇÐÄÖ±²¥

prof.dr. MJ (Maarten) IJzerman

Biography

Maarten IJzerman (Dutch, Australian) is Dean of Erasmus School of Health Policy & Management and Professor of Cancer Health Services Research in Erasmus University. He also is (honorary) Professor in the Melbourne School of Population and Global Health and University of Melbourne Centre for Cancer Research. 

Maarten studied biomedical sciences (Radboud University Nijmegen, Faculty of Medical Sciences) and received his PhD in biomedical engineering (University of Twente, Faculty of Electrical Engineering).

In his research he takes a systems approach to health (technology) innovation and cancer management. He leads work in genomics enable precision oncology including improving cancer outcomes across the whole episode of care. Current initiatives aim to promote access to cancer care across the globe, with an emphasis on global health challenges and healthcare sustainability.  

Maarten is an INSEAD alumnus (International Directors Program, Singapore) and received certificates from University of York (Health Economics) and Colombia University (Corporate Finance) and serves as a non-executive board member in the non-profit sector.

Erasmus School of Health Policy & Management

Dean | Erasmus School of Health Policy & Management
Email
ijzerman@eshpm.eur.nl

Erasmus School of Health Policy & Management

Full professor | Health Services Management & Organisation (HSMO)
Email
ijzerman@eshpm.eur.nl

More information

Work

  • Praveen Thokala, Nancy Devlin, Kevin Marsh, Rob Baltussen, Meindert Boysen, Zoltan Kalo, Thomas Longrenn, Filip Mussen, Stuart Peacock, John Watkins & Maarten Ijzerman (2016) - - Value in Health, 19 (1), 125-137 - doi: -
  • A. Brett Hauber, Juan Marcos González, Catharina G.M. Groothuis-Oudshoorn, Thomas Prior, Deborah A. Marshall, Charles Cunningham, Maarten J. IJzerman & John F.P. Bridges (2016) - - Value in Health, 19 (4), 300-315 - doi: -
  • William V Padula, Noemi Kreif, David J Vanness, Blythe Adamson, Juan-David Rueda, Federico Felizzi, Pall Jonsson, Maarten J IJzerman, Atul Butte & William Crown (2022) - - Value in Health, 25 (7), 1063-1080 - doi: -
  • Maarten J. Ijzerman & Lotte M.G. Steuten (2011) - - Applied Health Economics and Health Policy, 9 (5), 331-347 - doi: -
  • Koen Degeling, Nancy N. Baxter, Jon Emery, Mark A. Jenkins, Fanny Franchini, Peter Gibbs, G. Bruce Mann, Grant McArthur, Benjamin J. Solomon & Maarten J. IJzerman (2021) - - Asia-Pacific Journal of Clinical Oncology, 17 (4), 359-367 - doi: -
  • Sophie O’Haire, Koen Degeling, Fanny Franchini, Ben Tran, Stephen J. Luen, Clara Gaff, Kortnye Smith, Stephen Fox, Jayesh Desai & Maarten IJzerman (2022) - - Targeted Oncology, 17 (5), 539-548 - doi: -
  • Martin Vu, Koen Degeling, Ella R. Thompson, Piers Blombery, David Westerman & Maarten J. IJzerman (2022) - - European Journal of Haematology, 108 (6), 469-485 - doi: -
  • Mussab Fagery, Hadi A Khorshidi, Stephen Q Wong, Martin Vu & Maarten IJzerman (2023) - - PharmacoEconomics, 41 (10), 1229-1248 - doi: -
  • Koen Degeling, Maarten J. IJzerman, Catharina G.M. Groothuis-Oudshoorn, Mira D. Franken, Miriam Koopman, Mark S. Clements & Hendrik Koffijberg (2022) - - Value in Health, 25 (1), 104-115 - doi: -
  • Sophie O’Haire, Fanny Franchini, Yoon Jung Kang, Julia Steinberg, Karen Canfell, Jayesh Desai, Stephen Fox & Maarten IJzerman (2023) - - Scientific Reports, 13 (1) - doi: -

  • Maarten IJzerman (20 September 2024) - Opinie: Mislukte concentratie kinderhartchirurgie leidt tot toekomstlessen
  • Maarten IJzerman & Stefan Sleijfer (6 June 2024) - Neem duurzaamheid en personeelstekorten mee in het pakketbeheer
  • Maarten IJzerman (10 May 2022) - Will Australia be left behind in the cancer genomics revolution?
  • Maarten IJzerman & Sarah-Jane Dawson (15 February 2021) - Testing, testing, testing: Can blood tests help detect cancers early?
  • Maarten IJzerman (29 September 2020) - Nieuwe kankermedicijnen: eerst veiligheid, dan snel naar patiënten
  • Maarten IJzerman (12 June 2020) - Costly, fatal delays, new model shows
  • Maarten IJzerman (1 May 2020) - How has the temporary closure of BreastScreen affected GPs?
  • Maarten IJzerman & Jon D. Emery (30 April 2020) - Is a delayed cancer diagnosis a consequence of COVID-19?
  • Maarten IJzerman (18 May 2019) - Improving Australia’s health system beyond the election
  • Maarten IJzerman & Kim Dalziel (16 May 2019) - Improving Australia’s health system beyond the election

    Laboratorium Microbiologie

    Start date approval
    January 2023
    End date approval
    November 2025
    Place
    HENGELO
    Description
    Lid Raad van Toezicht

    Erasmus Centrum voor Zorgbestuur b.v.

    Start date approval
    July 2023
    End date approval
    June 2026
    Place
    ROTTERDAM
    Description
    Lid Raad van Commissarisen ECZB b.v. namens de EUR

    Erasmus Trust Fund

    Start date approval
    September 2023
    End date approval
    August 2026
    Place
    ROTTERDAM
    Description
    Lid Bestuur Erasmus Trust Fund

    University of Melbourne

    Start date approval
    November 2023
    End date approval
    November 2026
    Place
    MELBOURNE
    Description
    Visiting professor honorary

    International Society for Pharmacoeconomics ISPOR

    Start date approval
    February 2024
    End date approval
    February 2027
    Place
    PHILADELPHIA
    Description
    Chair Health Sciences Policy Council

    Erasmus Enterprise b.v.

    Start date approval
    May 2024
    End date approval
    May 2026
    Place
    ROTTERDAM
    Description
    Commissaris

    Compare @count study programme

    • @title

      • Duration: @duration
    Compare study programmes